Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight
The personalized medicine market is experiencing strong growth driven by advances in genomics, biomarker-based diagnostics, and targeted therapies. The increasing prevalence of chronic diseases and cancer is accelerating demand for tailored treatment approaches that improve efficacy and reduce adverse effects. Technological innovations such as next-generation sequencing and AI-powered data analytics are further enabling precise patient stratification.New York, USA, May 11, 2026 (GLOBE NEWSWIRE)
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.